Interesting facts
Interesting Facts about (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one
This fascinating compound combines a unique structure with potential applications in various fields of chemistry and pharmacology. Here are some interesting aspects of (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one:
- Stereochemistry: The stereochemistry of this compound is particularly noteworthy. With specific configurations at the 3 and 4 positions, this compound can exhibit different biological activities, influencing its interaction with biological systems.
- Imidazole Link: The presence of a 3-methylimidazol-4-yl group contributes to the compound's properties, particularly enhancing its potential as a ligand in coordination chemistry and medicinal chemistry. Imidazoles are known for their biological significance and roles in numerous enzymatic processes.
- Tetrahydrofuran Ring: The tetrahydrofuran moiety provides a cyclic structure that is often associated with stability and reactivity, making it a valuable scaffold for further chemical modifications.
- Pharmaceutical Potential: Given its structural characteristics, this compound holds promise in drug design. It can serve as a lead compound in the development of new pharmaceuticals targeting various diseases.
- Research Interest: As a subject of academic research, compounds like this are often investigated for their potential effects in biochemistry and medicinal chemistry, providing insights into drug-receptor interactions.
- Applied Chemistry: The versatile nature of this compound allows chemists to explore its use in organic synthesis and materials science, potentially leading to innovative applications.
In conclusion, (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one showcases the intersection of organic chemistry and potential therapeutic applications, making it a compelling subject for further study in the scientific community.
Synonyms
pilocarpine
92-13-7
Pilokarpin
Pilocarpol
Syncarpine
Ocusert pilo
Pilocarpin
Spersacarpine
Pilokarpol
(+)-Pilocarpine
Ocusert pilo-20
Ocusert Pilo-40
Ocusert P 20
ocucarpine
Isoptocarpine
Pilocarpine chloride
Pilocarpinum
HSDB 3163
EINECS 202-128-4
UNII-01MI4Q9DI3
(3S,4R)-3-Ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one
01MI4Q9DI3
CHEBI:8207
DTXSID1021162
AI3-50523
CHEMBL550
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
(3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone
Pilocarpine [USP:BAN:JAN]
DTXCID901162
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]oxolan-2-one
(3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone
(3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S,4R)-
92-13-7 (FREE BASE)
NCGC00023339-09
Pilocarpine 100 microg/mL in Acetonitrile
2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)-
PILOCARPINE (MART.)
PILOCARPINE [MART.]
PILOCARPINE (USP-RS)
PILOCARPINE [USP-RS]
Pilocarpine (USP:BAN:JAN)
Pilocarpine nitrate salt
PILOCARPINE (USP MONOGRAPH)
PILOCARPINE [USP MONOGRAPH]
Pilocarpine, (+)-
CAS-92-13-7
Pilocarpine (JAN/USP)
Ocusert pilo-20 (TN)
Pilocarpina
Ocucarpine; Ocusert P 20; Ocusert Pilo
Spectrum_001107
Tocris-0694
PILOCARPINE [MI]
Prestwick0_000449
Prestwick1_000449
Prestwick2_000449
Prestwick3_000449
Spectrum2_001284
Spectrum3_000546
Spectrum4_000478
Spectrum5_001379
PILOCARPINE [JAN]
PILOCARPINE [HSDB]
PILOCARPINE [VANDF]
PILOCARPINUM [HPUS]
Lopac0_000950
Lopac0_000960
SCHEMBL15146
BSPBio_000498
BSPBio_002191
GTPL305
KBioGR_000956
KBioSS_001587
PILOCARPINE [WHO-DD]
BIDD:GT0217
DivK1c_000358
SPBio_001287
SPBio_002437
BPBio1_000548
CHEBI:39462
HY-B0726A
KBio1_000358
KBio2_001587
KBio2_004155
KBio2_006723
KBio3_001691
PILOCARPINE [ORANGE BOOK]
NINDS_000358
GLXC-20879
HMS2089K17
Tox21_110887
BDBM50008072
MFCD00153042
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one
AKOS016010311
Tox21_110887_1
(3S-CIS)-3-ETHYLDIHYDRO-4-
CCG-205031
DB01085
FP05587
SDCCGMLS-0003164.P005
SDCCGSBI-0050924.P006
IDI1_000358
NCGC00023339-03
NCGC00023339-06
NCGC00023339-07
NCGC00023339-08
NCGC00023339-10
NCGC00023339-11
NCGC00023339-12
NCGC00023339-13
NCGC00023339-14
NCGC00023339-16
NCGC00023339-27
NCGC00023339-28
1ST40310
BS-18966
DA-76884
NCI60_004403
SBI-0050924.P004
CS-0013746
NS00007560
C07474
D00525
E87145
AB00053525-27
AB00053525_28
AB00053525_29
EN300-19632236
Q411461
BRD-K85090592-003-18-6
BRD-K85090592-003-19-4
BRD-K85090592-008-05-2
BRD-K85090592-008-15-1
BRD-K85090592-008-22-7
SR-01000075339-11
(3S,4R)-3-Ethyl-4-(1-methyl-1H-imidazol-5-ylmethyl)-4,5-dihydrofuran-2(3H)-one
rel-(3R,4S)-3-ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one
102282-25-7
202-128-4
Solubility of (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one
The solubility of (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one, with the chemical formula C9H14N2O2, can be described as follows:
In summary, the solubility of (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one is influenced by its polar characteristics and appropriate solvent interactions. Understanding its solubility profile is essential for applications in pharmaceutical formulations and other chemical processes.